NCT07567482 Exoskeleton-Assisted Mobility in Aging and in Parkinson's Disease
| NCT ID | NCT07567482 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre intégré de santé et de services sociaux de l'Outaouais |
| Condition | Parkinson's Disease (PD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 26 participants |
| Start Date | 2026-04-30 |
| Primary Completion | 2026-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 26 participants in total. It began in 2026-04-30 with a primary completion date of 2026-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will evaluate whether a wearable robotic exoskeleton can improve mobility, balance, and walking in healthy older adults and in individuals living with Parkinson's disease, populations at high risk of falls and mobility limitations. Participants will attend two laboratory sessions. The first session includes clinical assessments, fitting and familiarization with the exoskeleton, and interviews to explore user perceptions. The second session involves performing functional mobility tasks (e.g., walking, standing, turning) with and without the exoskeleton and under different assistance levels, while movement is measured using wearable sensors. The study will assess the immediate effects of the exoskeleton on mobility, compare assistance levels, identify which participants benefit most, and explore user experience and acceptability. Findings will help inform the development and implementation of assistive technologies to support mobility in healthy aging and in individuals with Parkinson's disease.
Eligibility Criteria
Participants with Parkinson's disease Inclusion Criteria: * Ability to walk for at least 30 minutes with or without minimal aid * Diagnosis of idiopathic Parkinson's disease * Hoehn and Yahr stage 1 to 4 Exclusion Criteria: * Height smaller than 152 cm * Severe vascular conditions of the lower limbs that may limit mobility or pose a risk. * Presence of any implantable or external life-sustaining medical device such as a pacemaker * Severe osteoporosis or high risk of fractures * Contra-indication to the required physical effort * Severe cognitive impairment (MoCA \< 21) * Presence of neurological disorders, lower-limb injuries, or other conditions interfering with mobility, other than Parkinson's disease. Healthy elderly participants without Parkinson's disease Inclusion Criteria: * Ability to walk for at least 30 minutes with or without minimal aid * Age ≥ 65 years old Exclusion Criteria: * Height smaller than 152 cm * Severe vascular conditions of the lower limbs that may limit mobility or pose a risk. * Presence of any implantable or external life-sustaining medical device such as a pacemaker * Severe osteoporosis or high risk of fractures * Contra-indication to the required physical effort * Severe cognitive impairment (MoCA \< 21) * Presence of neurological disorders, lower-limb injuries, or other conditions interfering with mobility
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07567482 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Parkinson's Disease (PD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07567482 currently recruiting?
Yes, NCT07567482 is actively recruiting participants. Contact the research team at alexandra.potvin-desrochers@ssss.gouv.qc.ca for enrollment information.
Where is the NCT07567482 trial being conducted?
This trial is being conducted at Gatineau, Canada.
Who is sponsoring the NCT07567482 clinical trial?
NCT07567482 is sponsored by Centre intégré de santé et de services sociaux de l'Outaouais. The trial plans to enroll 26 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.